NFKB1 and infection: Because tulobuterol inhibited NF-κB activation and reduced cytokine concentration in the supernatants before RV14 infection in the present study, the attenuation of the production of inflammatory cytokines might be due to the inhibition of NF-κB activation by tulobuterol.